Challenge: ONCONOVA (now TRAWS Pharma) is a small biotech startup that needed to differentiate themselves from other companies running clinical trials in MDS and pancreatic cancer. They had two target audiences that needed to be approached differently. More clinical investigators were needed to increase the enrollment of suitable patients for their clinical trial program and their second target was venture capital to allow the company to fund their aggressive clinical trial program

Strategic Approach: Developed unique tagline Targeting Cancer and Protecting Healthy Cells which simply explained how their therapeutic approach limited cardiotoxicity; this was compelling to both clinicl investigators and venture capital. Implemented striking clinical trial recruitment aids that were compelling investigators that had patients who were failing their current therapy